Page last updated: 2024-11-11

3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide: found in high concentration in Spinacia oleracea following administration of diphenyl ether herbicides; structure in first source; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Spinaciagenus[no description available]AmaranthaceaeA family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.[MeSH]
Spinacia oleraceaspeciesA widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. (From American Heritage Dictionary, 1982)[MeSH]AmaranthaceaeA family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.[MeSH]

Cross-References

ID SourceID
PubMed CID5352115
CHEMBL ID226588
CHEBI ID67408
MeSH IDM0102278

Synonyms (31)

Synonym
83608-86-0
(e)-3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide
2-propenamide, 3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-, (e)-
hmp-hmpep
3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide
78510-19-7
NSC723670 ,
n-trans-feruloylmethoxytyramine
(e)-3-(4-hydroxy-3-methoxy-phenyl)-n-[2-(4-hydroxy-3-methoxy-phenyl)ethyl]prop-2-enamide
nsc-723670
chebi:67408 ,
CHEMBL226588 ,
(e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]prop-2-enamide
bdbm50349821
n-trans-feruloyl-3-methoxytyramine
n-feruloyl-3-methoxytyramine
AKOS025288021
trans-n-feruloyl-3-o-methyldopamine
(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide
n-feruloyl-3-methoxytyramine, (e)-
693Y4AOA91 ,
2-propenamide, 3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-, (2e)-
n-transferuloyl 3-o-methyldopamine
trans-feruloylmethoxytyramine
feruloylhomovanillylamine
unii-693y4aoa91
(e)-n-feruloyl-3-methoxytyramine
Q27135870
FS-9038
E88662
DTXSID201304540
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxycinnamic acidAny member of the class of cinnamic acids carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)1,000.00000.03403.987110.0000AID610480
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID610482Cytotoxicity against mouse B16F10 cells up to 200 ug/mL2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
AID610481Antimelanogenic activity in alpha-MSH-stimulated mouse B16F10 cells pretreated for 30 mins before alpha-MSH challenge measured after 48 hrs by ELISA reader2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
AID289063Growth inhibition of HepG2 cells2007Journal of natural products, Jun, Volume: 70, Issue:6
Bioactive polyketides from Peperomia duclouxii.
AID479064Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks2010Journal of natural products, May-28, Volume: 73, Issue:5
Secondary metabolites from the roots of Litsea hypophaea and their antitubercular activity.
AID289061Growth inhibition of WI38 cells2007Journal of natural products, Jun, Volume: 70, Issue:6
Bioactive polyketides from Peperomia duclouxii.
AID289062Growth inhibition of VA13 cells2007Journal of natural products, Jun, Volume: 70, Issue:6
Bioactive polyketides from Peperomia duclouxii.
AID1754175Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Tulipiferamide A, an Alkamide from
AID1776041Antineuroinflammatory activity against mouse BV2 cells assessed as inhibition of LPS-induced NO production incubated for 20 hrs by Griess assay
AID610480Inhibition of mushroom tyrosinase using L-DOPA after 10 mins by ELISA reader2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.75 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]